The Shock Index: is it ready for primetime?
نویسندگان
چکیده
The rapid and accurate prediction of the need for massive transfusion in bleeding trauma patients remains a challenge. Various models have been proposed to anticipate massive transfusion with variable success. The current study by Mutschler and colleagues proposes four classes of shock as defined by the Shock Index and examines its ability to predict the need for massive transfusion. This model demonstrates promise as a practical tool in acute decision-making for transfusion after injury.
منابع مشابه
Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “RecombinantHuman Insulin LikeGrowth Factor-1 Treatment: Ready for PrimeTime” by Bright GM,
متن کامل
The relationship of shock index (SI) with trauma patients’ mortality after the first 24 hours of admission at Khatam-aL-Anbia Hospital in Iranshahr
Background: The Trauma is one of the most important health problems and a leading cause of death in 4th decade of life. Mortality due to accidents has a critical situation in Iran and mortality rate is increasing10-15% annually. Aim: To assess the relationship of shock index with trauma patient’s mortality after first 24 hours of admission at Khatam-al-Anbia Hospital in Iranshahr. Method A cros...
متن کاملReinvestigation of Oil Price-Stock Market Nexus in Iran: A SVAR Approach
In this paper we investigate the effect of oil price shocks on stock market index in Iran, by using of a structural VAR (SVAR) approach. We used four variables in the model namely Kilian index, global oil supply, real oil price and real stock market index. The data are monthly and spanning the period 1997M10-2014M12. We identify the effect of four different shocks on stock market including oil ...
متن کاملIs clinical virtual reality ready for primetime?
OBJECTIVE Since the mid-1990s, a significant scientific literature has evolved regarding the outcomes from the use of what we now refer to as clinical virtual reality (VR). This use of VR simulation technology has produced encouraging results when applied to address cognitive, psychological, motor, and functional impairments across a wide range of clinical health conditions. This article addres...
متن کاملBiomarkers for pancreatic cancer: is it ready for primetime?
Standard treatment for advanced pancreatic cancer has had minimal impact on natural course of the disease. Current standard chemotherapy for healthy, robust patients remains FOLFIRINOX (5fluorouracil, leucovorin, oxaliplatin, and irinotecan) chemotherapy which showed 4-month overall survival benefit compared to gemcitabine alone [2]. Recently MPACT study showed that adding nabpaclitaxel to gemc...
متن کامل